Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2018-12, Vol.29 (12), p.2396-2398
Hauptverfasser:	Sen, S., Carmagnani Pestana, R., Hess, K., Viola, G.M., Subbiah, V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - adverse effects Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use Clinical Trials, Phase I as Topic CTLA-4 Antigen - antagonists & inhibitors CTLA-4 Antigen - immunology Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - immunology Humans Letters to the Editor Neoplasm Staging Neoplasms - drug therapy Neoplasms - immunology Neoplasms - mortality Neoplasms - pathology Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology Progression-Free Survival Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!